Related Experiment Video
Updated: Jun 21, 2026
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
15.2K
Photodynamic Therapy and Immune Checkpoint Blockade†
Gwendolyn M Cramer1, Edmund K Moon2, Keith A Cengel1
1Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Photochemistry and Photobiology
|June 24, 2020
Summary
Immune checkpoint inhibitors targeting PD-1 and CTLA-4 show promise in cancer treatment. Combining them with photodynamic therapy (PDT) may enhance antitumor immunity and treatment efficacy.
Area of Science:
- Immunology
- Oncology
- Photochemistry
Background:
- Immune checkpoints, such as PD-1 and CTLA-4, regulate immune responses but are often upregulated in cancer, hindering antitumor immunity.
- Monoclonal antibodies targeting these checkpoints have demonstrated clinical efficacy across various cancers.
- Photodynamic therapy (PDT) is a localized cancer treatment that utilizes light activation.
Purpose of the Study:
- To explore the potential of combining immune checkpoint inhibitors with photodynamic therapy (PDT) for cancer treatment.
- To investigate how PDT can enhance the efficacy of therapies targeting immune checkpoints.
Main Methods:
- Review of current literature on immune checkpoint inhibitors (PD-1, CTLA-4) and their role in cancer.
- Analysis of the mechanisms by which PDT affects the tumor microenvironment and immune system.
- Exploration of multimodal treatment strategies combining PDT with immune checkpoint blockade.
Main Results:
- PDT induces cell death and releases tumor-associated antigens and damage-associated molecular patterns (DAMPs).
- These PDT-induced signals promote the accumulation and maturation of antigen-presenting cells (APCs).
- PDT can reprogram the tumor microenvironment, making it more receptive to immune checkpoint inhibitors.
Conclusions:
- Combining PDT with immune checkpoint inhibitors offers a promising multimodal strategy for cancer therapy.
- PDT may enhance antitumor immunity by modulating the tumor microenvironment and improving APC function.
- This combination approach has the potential to improve treatment efficacy and potentially minimize side effects.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.